Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALDX

Aldeyra Therapeutics Inc

May 08 • 04:00PM ET

1.73

0.00 0.00 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: EYPT OCGN TRVI VNDA SGMO

| Held by: VTI IWM VXF IWO VTWO VHT IWC DFMC DFAS PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.46	Insider Own	7.44%	Shs Outstand	60.32M	Perf Week	8.81%
Market Cap	104.36M	Forward P/E	-	EPS next Y	-0.31	Insider Trans	1.70%	Shs Float	55.84M	Perf Month	8.81%
Enterprise Value	54.87M	PEG	-	EPS next Q	-0.10	Inst Own	64.81%	Short Float	9.93%	Perf Quarter	-68.72%
Income	-27.37M	P/S	-	EPS this Y	17.41%	Inst Trans	5.45%	Short Ratio	1.80	Perf Half Y	-64.91%
Sales	0.00M	P/B	2.48	EPS next Y	32.97%	ROA	-34.28%	Short Interest	5.54M	Perf YTD	-66.60%
Book/sh	0.70	P/C	1.61	EPS next 5Y	-	ROE	-51.76%	52W High	6.18 -71.98%	Perf Year	-19.91%
Cash/sh	1.08	P/FCF	-	EPS past 3/5Y	19.04% 12.61%	ROIC	-64.92%	52W Low	1.07 61.68%	Perf 3Y	-83.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.73% 6.70%	Perf 5Y	-86.14%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	53.00%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-72.05%
Dividend Ex-Date	-	Quick Ratio	2.69	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.50	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.69	EPS Q/Q	65.50%	SMA20	2.88%	Beta	1.16	Target Price	7.00
Payout	-	Debt/Eq	0.37	Sales Q/Q	-	SMA50	-29.83%	Rel Volume	0.27	Prev Close	1.73
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 12	SMA200	-61.47%	Avg Volume	3.08M	Price	1.73
IPO	May 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.43% -	Trades		Volume	819,626	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)